JP2010528045A5 - - Google Patents

Download PDF

Info

Publication number
JP2010528045A5
JP2010528045A5 JP2010509552A JP2010509552A JP2010528045A5 JP 2010528045 A5 JP2010528045 A5 JP 2010528045A5 JP 2010509552 A JP2010509552 A JP 2010509552A JP 2010509552 A JP2010509552 A JP 2010509552A JP 2010528045 A5 JP2010528045 A5 JP 2010528045A5
Authority
JP
Japan
Prior art keywords
cyclodextrin
composition
composition according
drug
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010509552A
Other languages
English (en)
Japanese (ja)
Other versions
JP5416095B2 (ja
JP2010528045A (ja
Filing date
Publication date
Priority claimed from US11/753,883 external-priority patent/US7658913B2/en
Application filed filed Critical
Publication of JP2010528045A publication Critical patent/JP2010528045A/ja
Publication of JP2010528045A5 publication Critical patent/JP2010528045A5/ja
Application granted granted Critical
Publication of JP5416095B2 publication Critical patent/JP5416095B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010509552A 2007-05-25 2008-05-22 腎毒性を低めるために有用な組成物及びその使用方法 Active JP5416095B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/753,883 US7658913B2 (en) 2005-11-28 2007-05-25 Compositions useful for reducing nephrotoxicity and methods of use thereof
US11/753,883 2007-05-25
PCT/US2008/064489 WO2008147856A1 (en) 2007-05-25 2008-05-22 Compositions useful for reducing nephrotoxicity and methods of use thereof

Publications (3)

Publication Number Publication Date
JP2010528045A JP2010528045A (ja) 2010-08-19
JP2010528045A5 true JP2010528045A5 (OSRAM) 2011-06-02
JP5416095B2 JP5416095B2 (ja) 2014-02-12

Family

ID=40076731

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010509552A Active JP5416095B2 (ja) 2007-05-25 2008-05-22 腎毒性を低めるために有用な組成物及びその使用方法

Country Status (10)

Country Link
US (5) US7658913B2 (OSRAM)
EP (1) EP2162138B1 (OSRAM)
JP (1) JP5416095B2 (OSRAM)
KR (1) KR20100023901A (OSRAM)
CN (1) CN101686991A (OSRAM)
AU (1) AU2008256808B2 (OSRAM)
BR (1) BRPI0812166A2 (OSRAM)
CA (1) CA2687574C (OSRAM)
MX (1) MX2009012523A (OSRAM)
WO (1) WO2008147856A1 (OSRAM)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7658913B2 (en) * 2005-11-28 2010-02-09 Verrow Pharmaceuticals, Inc. Compositions useful for reducing nephrotoxicity and methods of use thereof
RU2470636C2 (ru) 2007-04-27 2012-12-27 Сайдекс Фамэсьютиклз, Инк. Композиция клопидогреля и сульфоалкилового эфира циклодекстрина (варианты) и способы лечения заболеваний посредством названной композиции (варианты)
US8192721B2 (en) * 2007-12-13 2012-06-05 Verrow Pharmaceuticals, Inc. Compositions useful for reducing toxicity associated with gadolinium-based contrast agents
DK3100728T3 (da) 2009-05-13 2020-02-17 Cydex Pharmaceuticals Inc Farmaceutiske sammensætninger omfattende prasugrel og cyclodextrin-derivativ og fremgangsmåder til fremstilling og brug af samme
US20140377185A9 (en) * 2012-05-30 2014-12-25 Verrow Pharmaceuticals, Inc. Stabilized formulations containing iodinated contrast agents and cyclodextrins
JP6239282B2 (ja) * 2013-06-28 2017-11-29 日本食品化工株式会社 腎不全改善剤
WO2015147018A1 (ja) * 2014-03-28 2015-10-01 テルモ株式会社 炎症性自己免疫疾患治療用の注射用水性製剤
CN104280478B (zh) * 2014-11-03 2016-03-30 天津中医药大学 内源性小分子物质在快速检测肾毒性方面的应用
US10973912B2 (en) 2015-06-29 2021-04-13 President And Fellows Of Harvard College Treatment for myopathy
JP7204670B2 (ja) * 2017-05-03 2023-01-16 サイデックス・ファーマシューティカルズ・インコーポレイテッド シクロデキストリン及びブスルファンを含有する組成物
CN111419860A (zh) * 2020-03-19 2020-07-17 长春市儿童医院 一种肾小球分叶状肾病造模方法
CN114982708A (zh) * 2022-05-11 2022-09-02 成都医学院第一附属医院 一种小鼠造影剂肾病模型及其构建方法

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3426011A (en) * 1967-02-13 1969-02-04 Corn Products Co Cyclodextrins with anionic properties
US4247535A (en) * 1979-11-05 1981-01-27 American Cyanamid Company Modified cyclodextrin sulfate salts as complement inhibitors
US4371673A (en) 1980-07-21 1983-02-01 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Water soluble forms of retinoids
US4727064A (en) * 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
US4654325A (en) * 1984-05-24 1987-03-31 Selenke William M Medicament for reducing nephrotoxicity caused by positively charged agents such as aminoglycosides and methods of use thereof
ES8801168A1 (es) 1984-11-02 1987-02-16 Johnson Matthey Plc Procedimiento para la obtencion de un compuesto de platino para utilizar en quimioterapia del cancer.
US6407079B1 (en) 1985-07-03 2002-06-18 Janssen Pharmaceutica N.V. Pharmaceutical compositions containing drugs which are instable or sparingly soluble in water and methods for their preparation
JPH01501478A (ja) * 1986-11-25 1989-05-25 インスティテュト　オルガニチェスコゴ　シンテザ　アカデミイ　ナウク　ラトビイスコイ　エスエスアール ９―置換グアニン
US4877778A (en) * 1987-07-01 1989-10-31 The Children's Medical Center Corporation Method of enhancing lipophile transport using cyclodextrin derivatives
US5441944A (en) * 1989-04-23 1995-08-15 The Trustees Of The University Of Pennsylvania Substituted cyclodextrin sulfates and their uses as growth modulating agents
US5010092A (en) 1989-12-22 1991-04-23 Wisconsin Alumni Research Foundation Protection against chemically-induced kidney damage by methimazole
KR0166088B1 (ko) 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
AU6818094A (en) * 1993-04-22 1994-11-08 Depotech Corporation Cyclodextrin liposomes encapsulating pharmacologic compounds and methods for their use
US6540981B2 (en) * 1997-12-04 2003-04-01 Amersham Health As Light imaging contrast agents
US5906981A (en) * 1996-06-04 1999-05-25 Troy Corporation Halopropargyl inclusion complexes
US5780446A (en) 1996-07-09 1998-07-14 Baylor College Of Medicine Formulations of vesicant drugs and methods of use thereof
FR2754270B1 (fr) 1996-10-07 1998-12-24 Goemar Lab Sa Genes codant pour des iota-carraghenases et leur utilisation pour la production d'enzymes de biodegradation des carraghenanes
EP0979097B1 (en) 1997-03-15 2005-11-02 Nakamura, Toshikazu Hgf for treating acute renal failure
JPH11100401A (ja) * 1997-07-30 1999-04-13 Kikkoman Corp 環状オリゴ糖及びそれを含むレトロウイルス性疾患の予防または治療剤
US6077871A (en) * 1997-11-26 2000-06-20 Pfizer Inc. Droloxifene pharmaceutical compositions
US5994409A (en) 1997-12-09 1999-11-30 U.S. Bioscience, Inc. Methods for treatment of neuro--and nephro--disorders and therapeutic toxicities using aminothiol compounds
JP3229286B2 (ja) * 1999-04-02 2001-11-19 インターナショナル・ビジネス・マシーンズ・コーポレーション プリント回路基板の製造方法
BR0006838A (pt) 1999-07-01 2001-08-07 Italfarmaco Spa Complexos de paroxetina, com ciclodextrinas ou derivados de ciclodextrinas
GB9921958D0 (en) 1999-09-16 1999-11-17 Pharmacia & Upjohn Spa Formulations for parenteral use of estramustine phosphate and sulfoalkylether-cyclodextrins
GB9921954D0 (en) 1999-09-16 1999-11-17 Pharmacia & Upjohn Spa Formulations for parenteral use of estramustine phosphate with improved pharmacological properties
KR100358855B1 (ko) * 2000-02-29 2002-10-31 광주과학기술원 사이클로덱스트린 또는 그 유도체와 조영제의 포접 착체형성 방법
KR100362080B1 (ko) 2000-03-29 2002-11-23 광주과학기술원 고리 올리고당과 그들의 유도체를 이용한 조영제의 새로운포접 착체
ES2316445T3 (es) * 2000-05-02 2009-04-16 Theravance, Inc. Composicion que contiene una ciclodextrina y un antibiotico glicopeptidico.
US6903100B2 (en) * 2001-05-03 2005-06-07 Midamerica Neuroscience Research Foundation Use of regularly scheduled high dose intravenous methotrexate therapy, with interim administration of immunomodulatory agents, to treat multiple sclerosis and other diseases of the central nervous system
ITMI20012749A1 (it) * 2001-12-21 2003-06-21 Chiesi Farma Spa Procedimento per la preparazione mediante trattamento con microonde di composti di inclusione tra farmaco e ciclodestrine e prodotti ottenut
WO2003080080A1 (en) * 2002-03-21 2003-10-02 Regents Of The University Of Minnesota Cyclodextrin compositions and methods of treating viral infections
EP1556033A4 (en) 2002-05-17 2006-05-31 Celgene Corp METHODS AND COMPOSITIONS USING CYTOKINE INHIBITOR SELECTIVE MEDICAMENTS FOR THE TREATMENT AND MANAGEMENT OF CANCERS AND OTHER DISEASES
US20040048871A1 (en) * 2002-09-09 2004-03-11 Rowe Vernon D. Use of high dose intravenous methotrexate, with leucovorin rescue, to treat early multiple sclerosis and other diseases of the central nervous system
JP2004235128A (ja) 2002-12-04 2004-08-19 Dainippon Printing Co Ltd 有機ｅｌ素子およびその製造方法
GB0404487D0 (en) * 2004-02-28 2004-03-31 Protherics Molecular Design Lt Use of enzyme
GB0519391D0 (en) * 2005-09-22 2005-11-02 Aion Diagnostics Ltd Imaging agents
WO2007062403A2 (en) * 2005-11-28 2007-05-31 Vernon D Rowe Compositions useful for reducing nephrotoxicity and methods of use thereof
US7658913B2 (en) * 2005-11-28 2010-02-09 Verrow Pharmaceuticals, Inc. Compositions useful for reducing nephrotoxicity and methods of use thereof
JP4008481B2 (ja) * 2006-08-21 2007-11-14 独立行政法人科学技術振興機構 腎臓の薬物排泄機能に関与する有機アニオントランスポーター

Similar Documents

Publication Publication Date Title
JP2010528045A5 (OSRAM)
EP2579864A1 (en) Coordination complexes, pharmaceutical solutions comprising coordination complexes, and methods of treating patients
CA2687574C (en) Compositions useful for reducing nephrotoxicity and methods of use thereof
JP2015212268A5 (OSRAM)
JP6265964B2 (ja) 低投与量のジクロフェナク及びβ−シクロデキストリンの配合物
JP2014507421A5 (OSRAM)
JP2013522229A5 (OSRAM)
JP2008540499A5 (OSRAM)
JP2012521435A5 (OSRAM)
JP2012506872A5 (OSRAM)
JP2009541224A5 (OSRAM)
JP2006515866A5 (OSRAM)
JP2018510912A (ja) ポリアニオン性および非イオン性のシクロデキストリン系デンドリマーの医薬組成物およびその使用
JP7597778B2 (ja) シクロデキストリン及びブスルファンを含有する組成物
KR100685059B1 (ko) 펜타플루오로벤젠술폰아미드를 사용하는 복합 치료법
WO2020089286A1 (en) Cyclodextrin-based formulation of a bcl-2 inhibitor
RU2440113C2 (ru) Фармацевтическая композиция для инъекционного особенно целенаправленного местного применения
JP2008528617A5 (OSRAM)
JP2013525290A5 (OSRAM)
JP2014530200A5 (OSRAM)
JP2018504391A5 (OSRAM)
JP2014001204A (ja) 腫瘍細胞選択的抗がん剤
NZ592293A (en) Compositions comprising an oligosaccharide such as a cyclodextrin for reducing the nephrotoxicity of other drugs
JP2013506688A5 (OSRAM)
CN102083436A (zh) 抗肿瘤组合物和方法